Login to your account

Username *
Password *
Remember Me

B.1.351 strain of SARS-CoV-2 neutralization titer reduced 8- to 9-fold for Pfizer and AstraZeneca vaccinees. Convalescent plasma and therapeutic antibodies were less effective against this variant as well.

[Preprint] Oxford/AstraZeneca and Pfizer/BioNTech vaccines probably can still neutralize P.1 strain of SARS-CoV-2, but at lower levels

Antibody evasion by the Brazilian P.1 strain of SARS-CoV-2 – bioRxiv Commentary: Existing COVID vaccines may protect against Brazilian variant – Oxford study – Reuters  

The post [Preprint] Oxford/AstraZeneca and Pfizer/BioNTech vaccines probably can still neutralize P.1 strain of SARS-CoV-2, but at lower levels appeared first on Links Medicus.

SARS-CoV-2 variants B.1.351 and P.1 can escape from therapeutic antibodies and evade antibodies induced by infection or mRNA vaccination

SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies – Cell  

The post SARS-CoV-2 variants B.1.351 and P.1 can escape from therapeutic antibodies and evade antibodies induced by infection or mRNA vaccination appeared first on Links Medicus.

Infection and mRNA vaccine-induced immunity may be retained against SARS-CoV-2 variant B.1.1.7

Neutralizing Antibodies Against SARS-CoV-2 Variants After Infection and Vaccination – JAMA  

The post Infection and mRNA vaccine-induced immunity may be retained against SARS-CoV-2 variant B.1.1.7 appeared first on Links Medicus.

Expert consensus statements for the management of COVID-19-related acute respiratory failure

Expert consensus statements for the management of COVID-19-related acute respiratory failure using a Delphi method – Critical Care   Commentary on Twitter ?Expert consensus statements for the management of ?? COVID-19-related acute respiratory failure using a Delphi method.?????https://t.co/ujt8669VAb pic.twitter.com/AlT0ZkdKSc — RECAT??‍⚕️???‍⚕️ (@LeslieMegom) March 17, 2021  

The post Expert consensus statements for the management of COVID-19-related acute respiratory failure appeared first on Links Medicus.

Perspective | Five reasons why COVID herd immunity is probably impossible

Five reasons why COVID herd immunity is probably impossible – Nature  

The post Perspective | Five reasons why COVID herd immunity is probably impossible appeared first on Links Medicus.

Leprosy drug holds promise as at-home treatment for COVID-19

Leprosy drug holds promise as at-home treatment for COVID-19 – Sanford Burnham Prebys Medical Discovery Institute Original article: Clofazimine broadly inhibits coronaviruses including SARS-CoV-2 – Nature  

The post Leprosy drug holds promise as at-home treatment for COVID-19 appeared first on Links Medicus.

CDC: SARS-CoV-2 Variants of Concern

SARS-CoV-2 Variants – Centers for Disease Control and Prevention Commentaries: Coronavirus strains first detected in California are officially ‘variants of concern,’ CDC says – CNN AND CDC IDs new COVID-19 variants of concern as hot spots reemerge – CIDRAP  

The post CDC: SARS-CoV-2 Variants of Concern appeared first on Links Medicus.

SARS-CoV-2 transmission without symptoms

SARS-CoV-2 transmission without symptoms – Science (a few articles per month are free)  

The post SARS-CoV-2 transmission without symptoms appeared first on Links Medicus.

How do you treat coronavirus? Here are physicians’ best strategies

How do you treat coronavirus? Here are physicians’ best strategies – Science (a few articles per month are free)  

The post How do you treat coronavirus? Here are physicians’ best strategies appeared first on Links Medicus.